James Geraghty
Chairman
Palvella Therapeutics, Inc. (PVLA)Equibles does not estimate personal net worth.
Get an email with a short summary when Palvella Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get PVLA alertsAbout James Geraghty
James Geraghty is recorded as Chairman at Palvella Therapeutics, Inc. (PVLA). The newest filing on record that lists James Geraghty as Chairman at Palvella Therapeutics, Inc. (PVLA) is dated November 6, 2024. Palvella Therapeutics, Inc. reported in an 8-K filed December 16, 2024 that James Geraghty resigned as Director, effective December 13, 2024. Palvella Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Palvella Therapeutics, Inc. includes Wesley H. Kaupinen (CEO and Board Member), George M. Jenkins (Chairman and Board Member), Matthew E. Korenberg (CFO) and 7 others.
“James Geraghty, Michael Richman, Ann Barbier, MD., Ph.D., Peter Kiener, D. Phil., Matthew Sherman, M.D. and Maya R. Said, Sc.D., each resigned from the Board.”
Affiliation history
-
Current
Start not stated–present
Last confirmed November 6, 2024
-
Start not stated–2024-12-13
Company network
Leadership on record at Palvella Therapeutics, Inc.
- Wesley H. Kaupinen CEO, Board Member
- George M. Jenkins Chairman, Board Member
- Matthew E. Korenberg CFO
- Matthew Korenberg CFO
- Kathleen Goin COO
- Jeffrey Martini CTO
- Jeffrey Martini, Ph.D. CTO
- Christopher Kiritsy Board Member
- Elaine J. Heron Board Member
- Elaine J. Heron, Ph.D. Board Member